Synoptics Technologies Ltd.
Synoptics Technologies Ltd. (SYNOPTICS.NS) Stock Competitors & Peer Comparison
See (SYNOPTICS.NS) competitors and their performances in Stock Market.
Peer Comparison Table: NaN Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SYNOPTICS.NS | ₹59.85 | +5.00% | 483.4M | 11.95 | ₹4.77 | N/A |
| DOMS.BO | ₹2,342.60 | -1.10% | 144.3B | 65.05 | ₹36.54 | +0.13% |
| HEXAWARE.NS | ₹470.80 | +0.00% | 141.4B | 22.98 | ₹20.49 | N/A |
| SAFARIND.BO | ₹1,915.30 | -0.29% | 91.1B | 1394.97 | ₹1.37 | N/A |
| SHREMINVIT.NS | ₹118.00 | +0.00% | 72.1B | 7.51 | ₹15.72 | N/A |
| ENTERO.NS | ₹1,058.60 | +2.95% | 46.2B | 40.96 | ₹25.90 | N/A |
| ORIANA.NS | ₹1,842.00 | -4.87% | 39.1B | 24.21 | ₹79.49 | N/A |
| MEDIASSIST.NS | ₹387.20 | -0.36% | 28.8B | 49.28 | ₹7.85 | N/A |
| RPTECH.NS | ₹368.95 | +7.00% | 22.5B | 9.30 | ₹36.66 | +1.17% |
| ALPEXSOLAR.NS | ₹727.50 | -6.80% | 19.1B | 14.68 | ₹50.98 | N/A |
Stock Comparison
SYNOPTICS.NS vs DOMS.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, DOMS.BO has a market cap of 144.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while DOMS.BO trades at ₹2,342.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas DOMS.BO's P/E ratio is 65.05. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to DOMS.BO's ROE of +0.21%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to DOMS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check DOMS.BO's competition here
SYNOPTICS.NS vs HEXAWARE.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, HEXAWARE.NS has a market cap of 141.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while HEXAWARE.NS trades at ₹470.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas HEXAWARE.NS's P/E ratio is 22.98. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to HEXAWARE.NS's ROE of +0.25%. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to HEXAWARE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check HEXAWARE.NS's competition here
SYNOPTICS.NS vs SAFARIND.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SAFARIND.BO has a market cap of 91.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SAFARIND.BO trades at ₹1,915.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SAFARIND.BO's P/E ratio is 1394.97. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SAFARIND.BO's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SAFARIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SAFARIND.BO's competition here
SYNOPTICS.NS vs SHREMINVIT.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SHREMINVIT.NS has a market cap of 72.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SHREMINVIT.NS trades at ₹118.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SHREMINVIT.NS's P/E ratio is 7.51. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SHREMINVIT.NS's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. SYNOPTICS.NS has daily volatility of 1.43 and SHREMINVIT.NS has daily volatility of N/A.Check SHREMINVIT.NS's competition here
SYNOPTICS.NS vs ENTERO.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ENTERO.NS has a market cap of 46.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ENTERO.NS trades at ₹1,058.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ENTERO.NS's P/E ratio is 40.96. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ENTERO.NS's ROE of +0.06%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ENTERO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ENTERO.NS's competition here
SYNOPTICS.NS vs ORIANA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ORIANA.NS has a market cap of 39.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ORIANA.NS trades at ₹1,842.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ORIANA.NS's P/E ratio is 24.21. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ORIANA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ORIANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ORIANA.NS's competition here
SYNOPTICS.NS vs MEDIASSIST.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, MEDIASSIST.NS has a market cap of 28.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while MEDIASSIST.NS trades at ₹387.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas MEDIASSIST.NS's P/E ratio is 49.28. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to MEDIASSIST.NS's ROE of +0.10%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to MEDIASSIST.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check MEDIASSIST.NS's competition here
SYNOPTICS.NS vs RPTECH.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, RPTECH.NS has a market cap of 22.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while RPTECH.NS trades at ₹368.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas RPTECH.NS's P/E ratio is 9.30. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to RPTECH.NS's ROE of +0.14%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to RPTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check RPTECH.NS's competition here
SYNOPTICS.NS vs ALPEXSOLAR.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ALPEXSOLAR.NS has a market cap of 19.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ALPEXSOLAR.NS trades at ₹727.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ALPEXSOLAR.NS's P/E ratio is 14.68. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ALPEXSOLAR.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ALPEXSOLAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ALPEXSOLAR.NS's competition here
SYNOPTICS.NS vs VMARCIND.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, VMARCIND.NS has a market cap of 16.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while VMARCIND.NS trades at ₹680.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas VMARCIND.NS's P/E ratio is 26.87. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to VMARCIND.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to VMARCIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check VMARCIND.NS's competition here
SYNOPTICS.NS vs AIMTRON.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, AIMTRON.NS has a market cap of 16.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while AIMTRON.NS trades at ₹776.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas AIMTRON.NS's P/E ratio is 60.00. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to AIMTRON.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to AIMTRON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check AIMTRON.NS's competition here
SYNOPTICS.NS vs KRISHNADEF.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KRISHNADEF.NS has a market cap of 15.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KRISHNADEF.NS trades at ₹1,022.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KRISHNADEF.NS's P/E ratio is 49.25. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KRISHNADEF.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KRISHNADEF.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KRISHNADEF.NS's competition here
SYNOPTICS.NS vs ASHIKA.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ASHIKA.BO has a market cap of 14.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ASHIKA.BO trades at ₹378.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ASHIKA.BO's P/E ratio is -28.54. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ASHIKA.BO's ROE of +0.02%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ASHIKA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ASHIKA.BO's competition here
SYNOPTICS.NS vs GRNLAMIND.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GRNLAMIND.BO has a market cap of 13.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GRNLAMIND.BO trades at ₹556.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GRNLAMIND.BO's P/E ratio is 19.03. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GRNLAMIND.BO's ROE of -0.01%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to GRNLAMIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GRNLAMIND.BO's competition here
SYNOPTICS.NS vs VINYAS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, VINYAS.NS has a market cap of 12.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while VINYAS.NS trades at ₹1,001.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas VINYAS.NS's P/E ratio is 58.43. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to VINYAS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to VINYAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check VINYAS.NS's competition here
SYNOPTICS.NS vs LEMERITE.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, LEMERITE.NS has a market cap of 11.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while LEMERITE.NS trades at ₹454.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas LEMERITE.NS's P/E ratio is 94.55. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to LEMERITE.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to LEMERITE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check LEMERITE.NS's competition here
SYNOPTICS.NS vs KODYTECH.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KODYTECH.NS has a market cap of 11.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KODYTECH.NS trades at ₹860.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KODYTECH.NS's P/E ratio is 70.51. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KODYTECH.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KODYTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KODYTECH.NS's competition here
SYNOPTICS.NS vs GPTHEALTH.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GPTHEALTH.NS has a market cap of 10.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GPTHEALTH.NS trades at ₹127.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GPTHEALTH.NS's P/E ratio is 25.43. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GPTHEALTH.NS's ROE of +0.17%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to GPTHEALTH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GPTHEALTH.NS's competition here
SYNOPTICS.NS vs SARTELE.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SARTELE.NS has a market cap of 10.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SARTELE.NS trades at ₹213.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SARTELE.NS's P/E ratio is 12.83. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SARTELE.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SARTELE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SARTELE.NS's competition here
SYNOPTICS.NS vs KARNIKA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KARNIKA.NS has a market cap of 9.9B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KARNIKA.NS trades at ₹125.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KARNIKA.NS's P/E ratio is 45.24. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KARNIKA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KARNIKA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KARNIKA.NS's competition here
SYNOPTICS.NS vs VILAS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, VILAS.NS has a market cap of 9.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while VILAS.NS trades at ₹389.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas VILAS.NS's P/E ratio is 21.15. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to VILAS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to VILAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check VILAS.NS's competition here
SYNOPTICS.NS vs TAC.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, TAC.NS has a market cap of 8.7B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while TAC.NS trades at ₹385.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas TAC.NS's P/E ratio is 60.74. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to TAC.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to TAC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check TAC.NS's competition here
SYNOPTICS.NS vs REMUS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, REMUS.NS has a market cap of 8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while REMUS.NS trades at ₹652.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas REMUS.NS's P/E ratio is 18.97. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to REMUS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to REMUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check REMUS.NS's competition here
SYNOPTICS.NS vs PARIN.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, PARIN.NS has a market cap of 7.9B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while PARIN.NS trades at ₹707.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas PARIN.NS's P/E ratio is 102.68. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to PARIN.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to PARIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check PARIN.NS's competition here
SYNOPTICS.NS vs ACCENTMIC.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ACCENTMIC.NS has a market cap of 7.9B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ACCENTMIC.NS trades at ₹352.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ACCENTMIC.NS's P/E ratio is 22.05. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ACCENTMIC.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ACCENTMIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ACCENTMIC.NS's competition here
SYNOPTICS.NS vs DENTALKART.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, DENTALKART.NS has a market cap of 7.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while DENTALKART.NS trades at ₹443.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas DENTALKART.NS's P/E ratio is 44.85. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to DENTALKART.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to DENTALKART.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check DENTALKART.NS's competition here
SYNOPTICS.NS vs ZTECH.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ZTECH.NS has a market cap of 6.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ZTECH.NS trades at ₹512.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ZTECH.NS's P/E ratio is 32.03. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ZTECH.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ZTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ZTECH.NS's competition here
SYNOPTICS.NS vs GGBL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GGBL.NS has a market cap of 6.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GGBL.NS trades at ₹263.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GGBL.NS's P/E ratio is 13.46. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GGBL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to GGBL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GGBL.NS's competition here
SYNOPTICS.NS vs APS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, APS.NS has a market cap of 6.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while APS.NS trades at ₹307.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas APS.NS's P/E ratio is 15.56. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to APS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to APS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check APS.NS's competition here
SYNOPTICS.NS vs KILPEST.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KILPEST.BO has a market cap of 6.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KILPEST.BO trades at ₹808.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KILPEST.BO's P/E ratio is 18.32. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KILPEST.BO's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KILPEST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KILPEST.BO's competition here
SYNOPTICS.NS vs BAHETI.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, BAHETI.NS has a market cap of 6.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while BAHETI.NS trades at ₹599.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas BAHETI.NS's P/E ratio is 34.18. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to BAHETI.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to BAHETI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check BAHETI.NS's competition here
SYNOPTICS.NS vs DPEL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, DPEL.NS has a market cap of 6.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while DPEL.NS trades at ₹288.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas DPEL.NS's P/E ratio is 63.33. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to DPEL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to DPEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check DPEL.NS's competition here
SYNOPTICS.NS vs KRITIIND.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KRITIIND.BO has a market cap of 5.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KRITIIND.BO trades at ₹117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KRITIIND.BO's P/E ratio is 31.62. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KRITIIND.BO's ROE of -0.05%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KRITIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KRITIIND.BO's competition here
SYNOPTICS.NS vs MOS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, MOS.NS has a market cap of 5.7B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while MOS.NS trades at ₹21.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas MOS.NS's P/E ratio is 40.00. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to MOS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to MOS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check MOS.NS's competition here
SYNOPTICS.NS vs GICL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GICL.NS has a market cap of 5.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GICL.NS trades at ₹50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GICL.NS's P/E ratio is 172.41. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GICL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to GICL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GICL.NS's competition here
SYNOPTICS.NS vs CELLECOR.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, CELLECOR.NS has a market cap of 5.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while CELLECOR.NS trades at ₹26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas CELLECOR.NS's P/E ratio is 18.17. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to CELLECOR.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to CELLECOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check CELLECOR.NS's competition here
SYNOPTICS.NS vs TIRUPATI.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, TIRUPATI.NS has a market cap of 5.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while TIRUPATI.NS trades at ₹538.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas TIRUPATI.NS's P/E ratio is 38.10. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to TIRUPATI.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to TIRUPATI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check TIRUPATI.NS's competition here
SYNOPTICS.NS vs PCCL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, PCCL.NS has a market cap of 5.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while PCCL.NS trades at ₹230.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas PCCL.NS's P/E ratio is 57.42. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to PCCL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to PCCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check PCCL.NS's competition here
SYNOPTICS.NS vs GIRIRAJ.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GIRIRAJ.NS has a market cap of 5.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GIRIRAJ.NS trades at ₹154.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GIRIRAJ.NS's P/E ratio is 19.79. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GIRIRAJ.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to GIRIRAJ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GIRIRAJ.NS's competition here
SYNOPTICS.NS vs BASILIC.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, BASILIC.NS has a market cap of 5.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while BASILIC.NS trades at ₹214.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas BASILIC.NS's P/E ratio is 13.92. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to BASILIC.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to BASILIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check BASILIC.NS's competition here
SYNOPTICS.NS vs UNIHEALTH.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, UNIHEALTH.NS has a market cap of 4.9B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while UNIHEALTH.NS trades at ₹320.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas UNIHEALTH.NS's P/E ratio is 32.44. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to UNIHEALTH.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to UNIHEALTH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check UNIHEALTH.NS's competition here
SYNOPTICS.NS vs SJLOGISTIC.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SJLOGISTIC.NS has a market cap of 4.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SJLOGISTIC.NS trades at ₹312.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SJLOGISTIC.NS's P/E ratio is 8.87. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SJLOGISTIC.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SJLOGISTIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SJLOGISTIC.NS's competition here
SYNOPTICS.NS vs VINSYS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, VINSYS.NS has a market cap of 4.7B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while VINSYS.NS trades at ₹319.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas VINSYS.NS's P/E ratio is 15.60. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to VINSYS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to VINSYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check VINSYS.NS's competition here
SYNOPTICS.NS vs EFFWA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, EFFWA.NS has a market cap of 4.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while EFFWA.NS trades at ₹197.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas EFFWA.NS's P/E ratio is 23.07. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to EFFWA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to EFFWA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check EFFWA.NS's competition here
SYNOPTICS.NS vs KNAGRI.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KNAGRI.NS has a market cap of 4.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KNAGRI.NS trades at ₹182.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KNAGRI.NS's P/E ratio is 12.29. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KNAGRI.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KNAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KNAGRI.NS's competition here
SYNOPTICS.NS vs COOLCAPS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, COOLCAPS.NS has a market cap of 4.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while COOLCAPS.NS trades at ₹30.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas COOLCAPS.NS's P/E ratio is 30.82. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to COOLCAPS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to COOLCAPS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check COOLCAPS.NS's competition here
SYNOPTICS.NS vs VIVIANA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, VIVIANA.NS has a market cap of 4.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while VIVIANA.NS trades at ₹668.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas VIVIANA.NS's P/E ratio is 34.20. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to VIVIANA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to VIVIANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check VIVIANA.NS's competition here
SYNOPTICS.NS vs GRETEX.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GRETEX.NS has a market cap of 4.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GRETEX.NS trades at ₹263.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GRETEX.NS's P/E ratio is 281.25. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GRETEX.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to GRETEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GRETEX.NS's competition here
SYNOPTICS.NS vs PRAMARA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, PRAMARA.NS has a market cap of 4.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while PRAMARA.NS trades at ₹365.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas PRAMARA.NS's P/E ratio is 70.36. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to PRAMARA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to PRAMARA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check PRAMARA.NS's competition here
SYNOPTICS.NS vs PROV.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, PROV.NS has a market cap of 4.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while PROV.NS trades at ₹1,200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas PROV.NS's P/E ratio is 45.28. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to PROV.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to PROV.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check PROV.NS's competition here
SYNOPTICS.NS vs VISHNUINFR.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, VISHNUINFR.NS has a market cap of 4.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while VISHNUINFR.NS trades at ₹167.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas VISHNUINFR.NS's P/E ratio is 13.95. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to VISHNUINFR.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to VISHNUINFR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check VISHNUINFR.NS's competition here
SYNOPTICS.NS vs MEGATHERM.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, MEGATHERM.NS has a market cap of 4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while MEGATHERM.NS trades at ₹215.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas MEGATHERM.NS's P/E ratio is 18.64. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to MEGATHERM.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to MEGATHERM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check MEGATHERM.NS's competition here
SYNOPTICS.NS vs ABSMARINE.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ABSMARINE.NS has a market cap of 4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ABSMARINE.NS trades at ₹168.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ABSMARINE.NS's P/E ratio is 14.07. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ABSMARINE.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ABSMARINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ABSMARINE.NS's competition here
SYNOPTICS.NS vs SYSTANGO.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SYSTANGO.NS has a market cap of 3.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SYSTANGO.NS trades at ₹257.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SYSTANGO.NS's P/E ratio is 11.76. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SYSTANGO.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SYSTANGO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SYSTANGO.NS's competition here
SYNOPTICS.NS vs SHIVAUM.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SHIVAUM.NS has a market cap of 3.7B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SHIVAUM.NS trades at ₹275.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SHIVAUM.NS's P/E ratio is 74.32. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SHIVAUM.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SHIVAUM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SHIVAUM.NS's competition here
SYNOPTICS.NS vs ATMASTCO.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ATMASTCO.NS has a market cap of 3.7B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ATMASTCO.NS trades at ₹153.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ATMASTCO.NS's P/E ratio is 19.14. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ATMASTCO.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ATMASTCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ATMASTCO.NS's competition here
SYNOPTICS.NS vs CGRAPHICS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, CGRAPHICS.NS has a market cap of 3.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while CGRAPHICS.NS trades at ₹149.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas CGRAPHICS.NS's P/E ratio is 16.22. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to CGRAPHICS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to CGRAPHICS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check CGRAPHICS.NS's competition here
SYNOPTICS.NS vs SUPREMEPWR.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SUPREMEPWR.NS has a market cap of 3.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SUPREMEPWR.NS trades at ₹147.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SUPREMEPWR.NS's P/E ratio is 16.77. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SUPREMEPWR.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SUPREMEPWR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SUPREMEPWR.NS's competition here
SYNOPTICS.NS vs WSIND.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, WSIND.BO has a market cap of 3.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while WSIND.BO trades at ₹131.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas WSIND.BO's P/E ratio is -6.02. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to WSIND.BO's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to WSIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check WSIND.BO's competition here
SYNOPTICS.NS vs HIGREEN.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, HIGREEN.NS has a market cap of 3.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while HIGREEN.NS trades at ₹136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas HIGREEN.NS's P/E ratio is 32.25. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to HIGREEN.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to HIGREEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check HIGREEN.NS's competition here
SYNOPTICS.NS vs INFINIUM.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, INFINIUM.NS has a market cap of 3.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while INFINIUM.NS trades at ₹210.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas INFINIUM.NS's P/E ratio is 35.64. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to INFINIUM.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to INFINIUM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check INFINIUM.NS's competition here
SYNOPTICS.NS vs PRIZOR.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, PRIZOR.NS has a market cap of 3.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while PRIZOR.NS trades at ₹321.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas PRIZOR.NS's P/E ratio is 27.91. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to PRIZOR.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to PRIZOR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check PRIZOR.NS's competition here
SYNOPTICS.NS vs SAAKSHI.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SAAKSHI.NS has a market cap of 3.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SAAKSHI.NS trades at ₹182.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SAAKSHI.NS's P/E ratio is 69.21. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SAAKSHI.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SAAKSHI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SAAKSHI.NS's competition here
SYNOPTICS.NS vs ANNAPURNA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ANNAPURNA.NS has a market cap of 3.2B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ANNAPURNA.NS trades at ₹181.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ANNAPURNA.NS's P/E ratio is 14.39. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ANNAPURNA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ANNAPURNA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ANNAPURNA.NS's competition here
SYNOPTICS.NS vs SHREEKARNI.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SHREEKARNI.NS has a market cap of 3.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SHREEKARNI.NS trades at ₹436.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SHREEKARNI.NS's P/E ratio is 18.90. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SHREEKARNI.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SHREEKARNI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SHREEKARNI.NS's competition here
SYNOPTICS.NS vs SEJAL.BO Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SEJAL.BO has a market cap of 3.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SEJAL.BO trades at ₹307.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SEJAL.BO's P/E ratio is N/A. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SEJAL.BO's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to SEJAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SEJAL.BO's competition here
SYNOPTICS.NS vs DUGLOBAL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, DUGLOBAL.NS has a market cap of 3.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while DUGLOBAL.NS trades at ₹44.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas DUGLOBAL.NS's P/E ratio is 75.18. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to DUGLOBAL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to DUGLOBAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check DUGLOBAL.NS's competition here
SYNOPTICS.NS vs TECHLABS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, TECHLABS.NS has a market cap of 3.1B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while TECHLABS.NS trades at ₹185.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas TECHLABS.NS's P/E ratio is 26.53. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to TECHLABS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to TECHLABS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check TECHLABS.NS's competition here
SYNOPTICS.NS vs ESFL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ESFL.NS has a market cap of 3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ESFL.NS trades at ₹128.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ESFL.NS's P/E ratio is 31.27. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ESFL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ESFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ESFL.NS's competition here
SYNOPTICS.NS vs EFACTOR.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, EFACTOR.NS has a market cap of 3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while EFACTOR.NS trades at ₹223.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas EFACTOR.NS's P/E ratio is 12.11. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to EFACTOR.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to EFACTOR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check EFACTOR.NS's competition here
SYNOPTICS.NS vs RBMINFRA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, RBMINFRA.NS has a market cap of 3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while RBMINFRA.NS trades at ₹352.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas RBMINFRA.NS's P/E ratio is 12.86. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to RBMINFRA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to RBMINFRA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check RBMINFRA.NS's competition here
SYNOPTICS.NS vs INFOLLION.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, INFOLLION.NS has a market cap of 3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while INFOLLION.NS trades at ₹310.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas INFOLLION.NS's P/E ratio is 21.81. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to INFOLLION.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to INFOLLION.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check INFOLLION.NS's competition here
SYNOPTICS.NS vs TRANSTEEL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, TRANSTEEL.NS has a market cap of 3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while TRANSTEEL.NS trades at ₹138.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas TRANSTEEL.NS's P/E ratio is 22.32. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to TRANSTEEL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to TRANSTEEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check TRANSTEEL.NS's competition here
SYNOPTICS.NS vs ARIHANTACA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ARIHANTACA.NS has a market cap of 3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ARIHANTACA.NS trades at ₹466.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ARIHANTACA.NS's P/E ratio is 50.00. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ARIHANTACA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to ARIHANTACA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ARIHANTACA.NS's competition here
SYNOPTICS.NS vs SHERA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SHERA.NS has a market cap of 2.9B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SHERA.NS trades at ₹120.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SHERA.NS's P/E ratio is 15.26. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SHERA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SHERA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SHERA.NS's competition here
SYNOPTICS.NS vs MASON.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, MASON.NS has a market cap of 2.9B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while MASON.NS trades at ₹161.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas MASON.NS's P/E ratio is 85.94. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to MASON.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to MASON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check MASON.NS's competition here
SYNOPTICS.NS vs SAHAJSOLAR.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SAHAJSOLAR.NS has a market cap of 2.9B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SAHAJSOLAR.NS trades at ₹128.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SAHAJSOLAR.NS's P/E ratio is 12.13. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SAHAJSOLAR.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SAHAJSOLAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SAHAJSOLAR.NS's competition here
SYNOPTICS.NS vs PHANTOMFX.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, PHANTOMFX.NS has a market cap of 2.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while PHANTOMFX.NS trades at ₹216.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas PHANTOMFX.NS's P/E ratio is 10.08. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to PHANTOMFX.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to PHANTOMFX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check PHANTOMFX.NS's competition here
SYNOPTICS.NS vs WTICAB.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, WTICAB.NS has a market cap of 2.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while WTICAB.NS trades at ₹115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas WTICAB.NS's P/E ratio is 12.09. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to WTICAB.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to WTICAB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check WTICAB.NS's competition here
SYNOPTICS.NS vs SHEETAL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SHEETAL.NS has a market cap of 2.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SHEETAL.NS trades at ₹242.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SHEETAL.NS's P/E ratio is 30.15. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SHEETAL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SHEETAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SHEETAL.NS's competition here
SYNOPTICS.NS vs DYNAMIC.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, DYNAMIC.NS has a market cap of 2.8B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while DYNAMIC.NS trades at ₹121.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas DYNAMIC.NS's P/E ratio is 17.17. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to DYNAMIC.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to DYNAMIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check DYNAMIC.NS's competition here
SYNOPTICS.NS vs SKP.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, SKP.NS has a market cap of 2.7B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while SKP.NS trades at ₹168.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas SKP.NS's P/E ratio is 50.89. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to SKP.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to SKP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check SKP.NS's competition here
SYNOPTICS.NS vs YASHOPTICS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, YASHOPTICS.NS has a market cap of 2.7B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while YASHOPTICS.NS trades at ₹111.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas YASHOPTICS.NS's P/E ratio is 33.44. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to YASHOPTICS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to YASHOPTICS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check YASHOPTICS.NS's competition here
SYNOPTICS.NS vs CPS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, CPS.NS has a market cap of 2.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while CPS.NS trades at ₹1,084.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas CPS.NS's P/E ratio is 1445.19. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to CPS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to CPS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check CPS.NS's competition here
SYNOPTICS.NS vs GSMFOILS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GSMFOILS.NS has a market cap of 2.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GSMFOILS.NS trades at ₹205.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GSMFOILS.NS's P/E ratio is 16.39. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GSMFOILS.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to GSMFOILS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GSMFOILS.NS's competition here
SYNOPTICS.NS vs CMNL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, CMNL.NS has a market cap of 2.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while CMNL.NS trades at ₹107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas CMNL.NS's P/E ratio is 26.59. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to CMNL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to CMNL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check CMNL.NS's competition here
SYNOPTICS.NS vs LAKSHVILAS.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, LAKSHVILAS.NS has a market cap of 2.6B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while LAKSHVILAS.NS trades at ₹7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas LAKSHVILAS.NS's P/E ratio is -0.34. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to LAKSHVILAS.NS's ROE of -0.54%. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to LAKSHVILAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check LAKSHVILAS.NS's competition here
SYNOPTICS.NS vs CHAVDA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, CHAVDA.NS has a market cap of 2.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while CHAVDA.NS trades at ₹111.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas CHAVDA.NS's P/E ratio is 12.03. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to CHAVDA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to CHAVDA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check CHAVDA.NS's competition here
SYNOPTICS.NS vs KRISHCA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KRISHCA.NS has a market cap of 2.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KRISHCA.NS trades at ₹181.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KRISHCA.NS's P/E ratio is 21.37. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KRISHCA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KRISHCA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KRISHCA.NS's competition here
SYNOPTICS.NS vs FELIX.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, FELIX.NS has a market cap of 2.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while FELIX.NS trades at ₹183.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas FELIX.NS's P/E ratio is 17.50. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to FELIX.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to FELIX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check FELIX.NS's competition here
SYNOPTICS.NS vs COMMITTED.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, COMMITTED.NS has a market cap of 2.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while COMMITTED.NS trades at ₹212.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas COMMITTED.NS's P/E ratio is 23.91. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to COMMITTED.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to COMMITTED.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check COMMITTED.NS's competition here
SYNOPTICS.NS vs KOTYARK.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, KOTYARK.NS has a market cap of 2.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while KOTYARK.NS trades at ₹236.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas KOTYARK.NS's P/E ratio is 17.18. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to KOTYARK.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to KOTYARK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check KOTYARK.NS's competition here
SYNOPTICS.NS vs JAINAM.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, JAINAM.NS has a market cap of 2.5B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while JAINAM.NS trades at ₹205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas JAINAM.NS's P/E ratio is -107.69. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to JAINAM.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to JAINAM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check JAINAM.NS's competition here
SYNOPTICS.NS vs AVPINFRA.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, AVPINFRA.NS has a market cap of 2.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while AVPINFRA.NS trades at ₹95.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas AVPINFRA.NS's P/E ratio is 20.11. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to AVPINFRA.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to AVPINFRA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check AVPINFRA.NS's competition here
SYNOPTICS.NS vs GOYALSALT.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, GOYALSALT.NS has a market cap of 2.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while GOYALSALT.NS trades at ₹130.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas GOYALSALT.NS's P/E ratio is 18.11. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to GOYALSALT.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to GOYALSALT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check GOYALSALT.NS's competition here
SYNOPTICS.NS vs ANLON.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, ANLON.NS has a market cap of 2.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while ANLON.NS trades at ₹373.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas ANLON.NS's P/E ratio is 35.80. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to ANLON.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to ANLON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check ANLON.NS's competition here
SYNOPTICS.NS vs TCL.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, TCL.NS has a market cap of 2.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while TCL.NS trades at ₹97.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas TCL.NS's P/E ratio is 18.99. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to TCL.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is more volatile compared to TCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check TCL.NS's competition here
SYNOPTICS.NS vs PRATHAM.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, PRATHAM.NS has a market cap of 2.4B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while PRATHAM.NS trades at ₹131.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas PRATHAM.NS's P/E ratio is 17.25. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to PRATHAM.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to PRATHAM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check PRATHAM.NS's competition here
SYNOPTICS.NS vs AKIKO.NS Comparison February 2026
SYNOPTICS.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYNOPTICS.NS stands at 483.4M. In comparison, AKIKO.NS has a market cap of 2.3B. Regarding current trading prices, SYNOPTICS.NS is priced at ₹59.85, while AKIKO.NS trades at ₹217.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYNOPTICS.NS currently has a P/E ratio of 11.95, whereas AKIKO.NS's P/E ratio is 28.87. In terms of profitability, SYNOPTICS.NS's ROE is N/A, compared to AKIKO.NS's ROE of N/A. Regarding short-term risk, SYNOPTICS.NS is less volatile compared to AKIKO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYNOPTICS.NS.Check AKIKO.NS's competition here